Skip to main content
Fig. 5 | Journal of Pharmaceutical Policy and Practice

Fig. 5

From: Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians

Fig. 5

Information need about biologicals in general and biosimilars in specific among community pharmacists. EMA European Medicines Agency, FAMHP Federal Agency for Medicines and Health Products (Belgian National Competent Authority), KOL key opinion leader, LMWH low molecular weight heparins, N number, NIHDI National Institute for Health and Disability Insurance (Belgian national health insurer), TNF-alfa blockers tumor necrosis factor-alfa blockers

Back to article page

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us